Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Protein Design Labs, Roche deal

The companies partnered to co-develop and co-commercialize PDLI's Zenapax daclizumab for asthma and related

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE